Darbepoetin alfa administered every 3 weeks alleviates anaemia in patients with solid tumours receiving chemotherapy; results of a double-blind, placebo-controlled, randomised study

By Kotasek D.   Steger G.   Faught W.   Underhill C.   Poulsen E.   Colowick A.B.   Rossi G.   Mackey J.   for the AranespTM 980291 Study Group  

European Journal of Cancer, Vol. 39, Iss. 14, 2003-09 ,pp. : 2026-2034

Elsevier

Access to resources Recommend Favorite

Predicting cancer-associated anaemia in patients receiving non-platinum chemotherapy - results of a retrospective survey

By Coiffier B.   Guastalla J.-P.   Pujade-Lauraine E.   Bastit P.   for the Anemia Study Group  

European Journal of Cancer, Vol. 37, Iss. 13, 2001-09 ,pp. : 1617-1623

Elsevier

Access to resources Recommend Favorite

Management of chemotherapy-related anaemia with low-dose recombinant human erythropoietin in patients with small cell lung cancer

By Zarogoulidis K.   Papagiannis A.   Ziogas E.   Fahantidou E.   Dermitzakis G.   Gioulekas D.   Vamvalis C.  

European Journal of Cancer, Vol. 33, Iss. 14, 1997-12 ,pp. : 2428-2431

Elsevier

Access to resources Recommend Favorite

Incidence of Anaemia in Breast Cancer Patients Receiving Adjuvant Chemotherapy

By Denison U.  

Breast Cancer Research and Treatment, Vol. 79, Iss. 3, 2003-06 ,pp. : 347-353

Springer Publishing Company

Access to resources Recommend Favorite

CYP450 polymorphisms predict clinic outcomes to vinorelbine-based chemotherapy in patients with non-small-cell lung cancer

By Pan Ji-Hong   Han Jin-Xiang   Wu Jian-Mei   Sheng Li-Jun   Huang Hai-Nan  

Acta Oncologica, Vol. 46, Iss. 3, 2007-01 ,pp. : 361-366

Informa Healthcare

Access to resources Recommend Favorite